Novo Nordisk has a strong financial position and portfolio of weight-loss and diabetes treatments. See why NVO’s stock dip ...

Novo Nordisk said that patients taking a pill form of Wegovy in a clinical trial lost about as much weight as those who get ...

Wall Street rolled to more records on Thursday as Nvidia and Intel led a rally for technology stocks after announcing a deal that includes a $5 billion investment.

It’s unclear how much such a pill would cost, but Novo Nordisk’s Ozempic and Wegovy shots currently go for several hundred ...

Novo Nordisk's shares rise as Phase III trial shows its oral Wegovy pill achieves significant weight loss, offering a new ...

Novo Nordisk (NYSE: NVO) -- the original Ozempic stock -- jumped higher again Thursday after announcing results from a weight ...

Medicare and Medicaid coverage of GLP-1 weight loss drugs could be just what the doctor ordered for these two struggling ...

Pharmaceutical companies are racing to develop a GLP-1 weight-loss drug in pill form. Novo Nordisk says its oral semaglutide pill led to "significant weight loss" in a trial.

Roughly one out of every two people who start taking semaglutide (Wegovy; Novo Nordisk) to lose weight will stop taking the ...

Novo Nordisk's shares rose by 5.4% on Thursday as investors turned more positive about the Danish drugmaker's prospects ...

Over dinner, Samira Shamoon's slim, chic friend let her in on a little secret. She was dabbling with the latest craze backed ...

Nearly 12% of Americans have used GLP-1s like Ozempic and Wegovy, which require a weekly injection. A new study from Novo Nordisk offers encouraging news in the race to develop a pill version of the ...